Investment Thesis Report: Clinical Decision Support

In a growing, dynamic healthcare regulatory environment it is becoming consistently more important for vendors to provide extremely flexible software solutions to all clinicians. Clinical decision support systems are poised to become the user interface of choice for clinical interactions with health IT. FCA is interested in this space as an important investment opportunity.

Here is a brief excerpt of the report: “As decision support becomes a critical component of both healthcare delivery as well as regulatory compliance, the market is forecasted to grow from $3.79 billion in 2018 to $6.4 billion in 2024, a compounded annual growth rate (CAGR) of 9.3%. Historically, clinical decision support systems (CDSS) have been seen as an auxiliary tool to electronic health records (EHRs) and electronic medical records (EMRs) however recent market studies have pointed towards substantial adoption of CDSS in the area of patient surveillance and linkage between EHR / EMR complexity and clinical workflow”.

View the full report here (PDF).

Thanks to Blaine Davis for authoring this report.